Exosome as the Prognostic and Predictive Biomarker in EBC Patients
Clinical trial NCT05955521 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05955521
- Sponsor
- Samsung Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2023-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.